HR Execs on the Move

Enlitic

www.enlitic.com

 
Enlitic is focused on developing solutions that enhance clinical workflows, enable research and development, improve billing accuracy, and decrease risk. We`re not an AI company that only produces algorithms for detection and prioritization of specific diseases – point solutions. We`re a medical intelligence company that delivers solutions with a point; to enable better patient outcomes by enhancing what`s possible in data processes. We are working to eliminate inefficiencies in workflows and ensure medical information is more useful and more impactful for patient care.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.enlitic.com
  • 3420 East Harmony Road Suite 125
    Fort Collins, CO USA 80528
  • Phone: 877.365.4842

Executives

Name Title Contact Details
David Wilson
Vice President of Marketing and Communications Profile
Scott Stanton
Sales Director, OEM/VAR Profile
Ryan Lennartson
VP of People Operations Profile
Kevin Lyman
Chief Executive Officer Profile

Similar Companies

Paragon Intellectual Properties

Paragon Intellectual Properties is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Cagent Vascular

Cagent Vascular is leading the way for next generation technology for vessel dilatation.

sound advice audiology inc

sound advice audiology inc is a Portland, ME-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Motif Neurotech

Motif Neurotech is a clinical-stage company leading the development of minimally invasive neuromodulation therapeutics for mental health. The company`s lead product, for treatment resistant depression (TRD), is a miniature implant that is designed to treat TRD by increasing activity in the prefrontal cortex. Studies over 20 years show stimulation of the pre-frontal cortex effectively treats treatment resistant depression without the side effects of anti-depressants. However, existing brain stimulation treatments like transcranial magnetic stimulation (TMS) can be expensive and challenging for patients to access, with daily treatments required for six weeks that may need to be repeated. Human and large animal studies show Motif`s prototype stimulates target brain areas like TMS, and the company is preparing to begin clinical trials of their first chronic implants in 2025. Motif`s implant is enabled by patent-pending wireless magnetoelectric power transfer developed at Rice University. Motif`s founders and key team members are clinical, medical device and academic experts with over 5,000 surgical procedures and decades of medical device experience.

INNOVATIVE BIOCERAMIX

INNOVATIVE BIOCERAMIX INC. is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.